Arrhythmia Research Technology, Inc. Announces First Quarter 2012 Results
Investment in WirelessDx Continues to Impact Operating Results
Arrhythmia Research Technology, Inc. Receives NYSE Amex Exchange Compliance Notice
FITCHBURG, MA — (Marketwire) — 04/23/12 — Arrhythmia Research Technology, Inc. (NYSE Amex: HRT) (the "Company") announced that, on April 17, 2012, it received notice from the NYSE Amex LLC (the "Exchange") that it is not in compliance with certain of the Exchange-s continued listing standards as set forth in Sections 134 and 1101 of the Exchange-s Company Guide (the "Company Guide") as a result of the failure to file its annual report on Form 10-K on a timely b